Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helois Radford

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
The Journal of Biological Chemistry|May 27, 2014
Prions: generation and spread versus neurotoxicityMark Halliday, Helois Radford, Giovanna R Mallucci
Acta Neuropathologica|October 10, 2015
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementiaHelois Radford, Julie A Moreno, Nicholas Verity, et al.
Science Signaling|August 14, 2020
Targeting the kinase insert loop of PERK selectively modulates PERK signaling without systemic toxicity in miceDaniel T Hughes, Mark Halliday, Heather L Smith, et al.
Science Translational Medicine|October 11, 2013
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected miceJulie A Moreno, Mark Halliday, Colin Molloy, et al.
Brain : a Journal of Neurology|April 22, 2017
Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in miceMark Halliday, Helois Radford, Karlijn A M Zents, et al.
Nature|January 22, 2015
RBM3 mediates structural plasticity and protective effects of cooling in neurodegenerationDiego Peretti, Amandine Bastide, Helois Radford, et al.
Nature|May 25, 2012
Sustained translational repression by eIF2α-P mediates prion neurodegenerationJulie A Moreno, Helois Radford, Diego Peretti, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
The Journal of Biological Chemistry|May 27, 2014
Prions: generation and spread versus neurotoxicityMark Halliday, Helois Radford, Giovanna R Mallucci
Acta Neuropathologica|October 10, 2015
PERK inhibition prevents tau-mediated neurodegeneration in a mouse model of frontotemporal dementiaHelois Radford, Julie A Moreno, Nicholas Verity, et al.
Science Signaling|August 14, 2020
Targeting the kinase insert loop of PERK selectively modulates PERK signaling without systemic toxicity in miceDaniel T Hughes, Mark Halliday, Heather L Smith, et al.
Science Translational Medicine|October 11, 2013
Oral treatment targeting the unfolded protein response prevents neurodegeneration and clinical disease in prion-infected miceJulie A Moreno, Mark Halliday, Colin Molloy, et al.
Brain : a Journal of Neurology|April 22, 2017
Repurposed drugs targeting eIF2α-P-mediated translational repression prevent neurodegeneration in miceMark Halliday, Helois Radford, Karlijn A M Zents, et al.
Nature|January 22, 2015
RBM3 mediates structural plasticity and protective effects of cooling in neurodegenerationDiego Peretti, Amandine Bastide, Helois Radford, et al.
Nature|May 25, 2012
Sustained translational repression by eIF2α-P mediates prion neurodegenerationJulie A Moreno, Helois Radford, Diego Peretti, et al.
Pageof 1